A novel asthma burden score that incorporated asthma exacerbations and healthcare utilization better reflected disease severity and predicted asthma remission
Twice-yearly lenacapavir (Sunlenca) substantially reduced HIV infection when used for preexposure prophylaxis (PrEP) in cisgender men and transgender or gender-nonbinary